HIKMA FDA Approval ANDA 206454

ANDA 206454

HIKMA

FDA Drug Application

Application #206454

Application Sponsors

ANDA 206454HIKMA

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS600MG/300ML (2MG/ML)0LINEZOLIDLINEZOLID

FDA Submissions

UNKNOWN; ORIG1AP2022-08-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206454
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"LINEZOLID","activeIngredients":"LINEZOLID","strength":"600MG\/300ML (2MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/22\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-08-22
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.